Thank You — Your Registration Is Confirmed
Welcome to the Jsuru Therapeutix investor community. Your support helps advance new therapeutic solutions for KRAS‑mutant pancreatic cancer.
What Happens Next
You will now receive:
- Early access to our upcoming investment campaign
- Scientific and milestone updates as we progress toward feasibility studies
- Invitations to investor briefings and webinars
- Priority access to our full investor materials
If you requested a call or the full deck, our team will reach out shortly.
Our Mission
Jsuru Therapeutix is developing a globally patented therapeutic platform designed to address KRAS‑mutant pancreatic cancer — a disease with limited treatment options and a profound unmet need.
Your support accelerates:
- Preclinical feasibility studies
- IND‑enabling research
- Strategic partnerships
- Future clinical development
Stay Connected
We’ll keep you informed as we reach key scientific and regulatory milestones.
If you have questions or would like to speak with our team, feel free to reach out anytime.
Return to Homepage
